- Home
- NDLS vs COCH Comparison
NDLS vs COCH Comparison
Compare NDLS & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- COCH
- Stock Information
- Founded
- NDLS 1995
- COCH 1995
- Country
- NDLS United States
- COCH United States
- Employees
- NDLS N/A
- COCH N/A
- Industry
- NDLS Restaurants
- COCH Blank Checks
- Sector
- NDLS Consumer Discretionary
- COCH Finance
- Exchange
- NDLS Nasdaq
- COCH Nasdaq
- Market Cap
- NDLS 32.9M
- COCH 31.6M
- IPO Year
- NDLS 2013
- COCH N/A
- Fundamental
- Price
- NDLS $0.73
- COCH $1.57
- Analyst Decision
- NDLS Strong Buy
- COCH Strong Buy
- Analyst Count
- NDLS 2
- COCH 2
- Target Price
- NDLS $3.00
- COCH $9.25
- AVG Volume (30 Days)
- NDLS 206.5K
- COCH 19.0K
- Earning Date
- NDLS 08-06-2025
- COCH 08-11-2025
- Dividend Yield
- NDLS N/A
- COCH N/A
- EPS Growth
- NDLS N/A
- COCH N/A
- EPS
- NDLS N/A
- COCH N/A
- Revenue
- NDLS $495,670,000.00
- COCH $212,000.00
- Revenue This Year
- NDLS $5.37
- COCH $8.04
- Revenue Next Year
- NDLS $0.68
- COCH $15.39
- P/E Ratio
- NDLS N/A
- COCH N/A
- Revenue Growth
- NDLS N/A
- COCH N/A
- 52 Week Low
- NDLS $0.55
- COCH $1.21
- 52 Week High
- NDLS $1.83
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- NDLS 52.39
- COCH 58.35
- Support Level
- NDLS $0.66
- COCH $1.40
- Resistance Level
- NDLS $0.82
- COCH $1.53
- Average True Range (ATR)
- NDLS 0.07
- COCH 0.09
- MACD
- NDLS 0.00
- COCH 0.02
- Stochastic Oscillator
- NDLS 89.29
- COCH 99.95
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.